With a significant expansion announced in March, including a second outpatient center, renovations to its main research and administration location and related renovations at Carolinas Medical Center, Levine Cancer Institute has experienced tremendous growth in its short history.
The new and expanded facilities will allow for further development of several cancer treatment areas, including heightened research efforts around novel treatments, as well as improvements to existing survivorship, palliative and rehabilitation programs that will support patients and their families throughout their care journey.
The new $150 million investment would include the construction of a seven-floor 260,000-square-foot advanced outpatient center adjacent to the Institute’s research and administration headquarters. This will expand hematologic, thoracic and gastrointestinal oncology practices available in the region. The Institute will also expand hematologic oncology, infusion capacity and specialty pharmacy capabilities, and will continue to grow its survivorship programs, fully integrated palliative services, rehabilitation and telemedicine services.
“The need for comprehensive cancer care in this region continues to grow, and this expansion will help ensure that we can meet that need, through providing the very best care to patients regardless of where they live,” said
Derek Raghavan, MD, president of Levine Cancer Institute. “This growth supports our ongoing mission to build a world-class, systemwide network anchored by advanced treatments here in Charlotte and extensive collaboration with hospitals and outpatient centers in North and South Carolina.”
In addition to the new building, enhancements will include the brachytherapy and urological programs. A portion of the funding will also be used to create a 32-bed advanced clinical unit in Carolinas Medical Center capable of treating all advanced cancer patients, which will support the Institute's blood and marrow transplant unit, which has surpassed expectations since its opening in January 2014.
Levine Cancer Institute's continued growth has been significant over recent years, with additional clinical space at
Carolinas HealthCare System Anson,
Carolinas HealthCare System Union,
Carolinas HealthCare System Pineville,
Carolinas HealthCare System NorthEast,
Carolinas HealthCare System Stanly,
Levine Cancer Institute - Rock Hill, Levine Cancer Institute - Carolinas Lakes, a new Phase I clinical trials unit at
Roper Hospital, and expansion into Cleveland and Columbus counties. Levine Cancer Institute currently has 25 sites within the System’s geographic footprint.
Access to cancer treatment is a crucial measurement to assess cancer care across the region and the country and is driving the expansion for Levine Cancer Institute. The Institute is a leading voice in a narrative that underscores the fact that access to world-class care, clinical trials and innovative research is foundational to transforming cancer care in this country.
